TY - JOUR
T1 - Altered T cell development in human thymorea is related to impairment of MHC class II transactivator expression induced by interferon-gamma (IFN-γ)
AU - Kadota, Y.
AU - Okumura, Meinoshin
AU - Miyoshi, S.
AU - Kitagawa-Sakakida, S.
AU - Inoue, M.
AU - Shiono, H.
AU - Maeda, Y.
AU - Kinoshita, T.
AU - Shirakura, R.
AU - Matsuda, H.
PY - 2000
Y1 - 2000
N2 - Thymoma is known to contain CD4+CD8+ T cells, indicating that neoplastic epithelial cells of thymoma have a function as thymic cortical epithelium. However, it has been shown that there is an impairment of CD4+ T cell development in thymoma and that IFN-γ-induced HLA-DR expression on cultured thymic epithelial cells (TEC) derived from thymoma is decreased when compared with the normal thymus. MHC class II transactivator (CIITA) is known to play a critical role in IFN-γ-induced MHC II expression. In this study, we attempted to elucidate whether CIITA is responsible for the impaired up- regulation of MHC II molecules in response to IFN-γ in thymoma TEC. A quantitative reverse transriptase-polymerase chain reaction examination revealed that the induced level of CIITA was significantly lower in thymoma TEC than in normal TEC. The induced levels of invariant chain (Ii) and HLA-DR in thymoma TEC were correlated with CIITA expression. The proportion of CD3+ cells in the CD+CD8- subset in thymoma was also correlated with CIITA expression. A gel mobility shift assay however, revealed translocation of STAT1 to the nucleus in thymoma as well as normal TEC. Intercellular adhesion molecule-1 was up-regulated in the thymoma TEC to a level similar to normal TEC in response to IFN-γ. These results indicate that impaired up- regulation of HLA-DR in response to IFN-γ results from insufficient induction of CIITA, but not from the signal from IFN-γ receptor to the nucleus. The abnormal regulation of HLA-DR expression caused by impaired induction of CIITA may affect CD4+ T cell development in thymoma.
AB - Thymoma is known to contain CD4+CD8+ T cells, indicating that neoplastic epithelial cells of thymoma have a function as thymic cortical epithelium. However, it has been shown that there is an impairment of CD4+ T cell development in thymoma and that IFN-γ-induced HLA-DR expression on cultured thymic epithelial cells (TEC) derived from thymoma is decreased when compared with the normal thymus. MHC class II transactivator (CIITA) is known to play a critical role in IFN-γ-induced MHC II expression. In this study, we attempted to elucidate whether CIITA is responsible for the impaired up- regulation of MHC II molecules in response to IFN-γ in thymoma TEC. A quantitative reverse transriptase-polymerase chain reaction examination revealed that the induced level of CIITA was significantly lower in thymoma TEC than in normal TEC. The induced levels of invariant chain (Ii) and HLA-DR in thymoma TEC were correlated with CIITA expression. The proportion of CD3+ cells in the CD+CD8- subset in thymoma was also correlated with CIITA expression. A gel mobility shift assay however, revealed translocation of STAT1 to the nucleus in thymoma as well as normal TEC. Intercellular adhesion molecule-1 was up-regulated in the thymoma TEC to a level similar to normal TEC in response to IFN-γ. These results indicate that impaired up- regulation of HLA-DR in response to IFN-γ results from insufficient induction of CIITA, but not from the signal from IFN-γ receptor to the nucleus. The abnormal regulation of HLA-DR expression caused by impaired induction of CIITA may affect CD4+ T cell development in thymoma.
KW - Invariant chain
KW - MHC class II transactivator
KW - T cell development
KW - Thymic epithelial tumour myasthenia gravis
UR - http://www.scopus.com/inward/record.url?scp=0033934538&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033934538&partnerID=8YFLogxK
U2 - 10.1046/j.1365-2249.2000.01256.x
DO - 10.1046/j.1365-2249.2000.01256.x
M3 - Article
C2 - 10886240
AN - SCOPUS:0033934538
SN - 0009-9104
VL - 121
SP - 59
EP - 68
JO - Clinical and Experimental Immunology
JF - Clinical and Experimental Immunology
IS - 1
ER -